Biology-guided radiotherapy in metastatic prostate cancer: time to push the envelope?

被引:1
|
作者
Lancia, Andrea [1 ]
Ingrosso, Gianluca [2 ]
Detti, Beatrice [3 ]
Festa, Eleonora [2 ]
Bonzano, Elisabetta [1 ]
Linguanti, Flavia [4 ]
Camilli, Federico [2 ]
Bertini, Niccolo [5 ]
La Mattina, Salvatore [1 ]
Orsatti, Carolina [5 ]
Francolini, Giulio [5 ]
Abenavoli, Elisabetta Maria [6 ]
Livi, Lorenzo [5 ]
Aristei, Cynthia [2 ]
de Jong, Dorine [7 ]
Al Feghali, Karine A. [7 ]
Siva, Shankar [8 ,9 ]
Becherini, Carlotta [5 ]
机构
[1] Ist Ricovero & Cura Carattere Sci IRCCS, San Matteo Hosp Fdn, Dept Radiat Oncol, Pavia, Italy
[2] Univ Perugia, Radiat Oncol Sect, Perugia, Italy
[3] Usl Ctr Toscana, Radiotherapy Unit Prato, Presidio Villa Fior, Prato, Italy
[4] Osped San Donato, Nucl Med Dept, Arezzo, Italy
[5] Azienda Osped Univ Careggi, Oncol Dept, Radiat Oncol Unit, Florence, Italy
[6] Careggi Univ Hosp, Nucl Med Div, Florence, Italy
[7] RefleXion Med Inc, Med Affairs, Hayward, CA 94545 USA
[8] Sir Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic, Australia
[9] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
radiotherapy; prostate cancer; PET/CT; biology-guided radiotherapy; metastases; BIOCHEMICAL RECURRENCE; RADICAL PROSTATECTOMY; ABLATIVE RADIATION; BODY RADIOTHERAPY; LYMPH-NODES; THERAPY; DISEASE; PET/CT; IMMUNOTHERAPY; STRATEGIES;
D O I
10.3389/fonc.2024.1455428
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The therapeutic landscape of metastatic prostate cancer has undergone a profound revolution in recent years. In addition to the introduction of novel molecules in the clinics, the field has witnessed a tremendous development of functional imaging modalities adding new biological insights which can ultimately inform tailored treatment strategies, including local therapies. The evolution and rise of Stereotactic Body Radiotherapy (SBRT) have been particularly notable in patients with oligometastatic disease, where it has been demonstrated to be a safe and effective treatment strategy yielding favorable results in terms of disease control and improved oncological outcomes. The possibility of debulking all sites of disease, matched with the ambition of potentially extending this treatment paradigm to polymetastatic patients in the not-too-distant future, makes Biology-guided Radiotherapy (BgRT) an attractive paradigm which can be used in conjunction with systemic therapy in the management of patients with metastatic prostate cancer.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Characterization of Biology-Guided Radiotherapy Accuracy as a Function of PET Tracer Uptake
    Han, B.
    Schmall, J.
    Bal, G.
    Khan, S.
    Voronenko, Y.
    Xu, S.
    Shi, L.
    Mitra, A.
    Groll, A.
    Sharma, S.
    Ramos, K.
    Shao, L.
    Narayanan, M.
    Olcott, P.
    Kuduvalli, G.
    Kovalchuk, N.
    Surucu, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E668 - E669
  • [22] Evaluation of Treatment Interruptions and Recovery during Biology-Guided Radiotherapy Delivery
    Bal, G.
    Xu, S.
    Shi, L.
    Voronenko, Y.
    Narayanan, M.
    Shao, L.
    Kuduvalli, G.
    Han, B.
    Kovalchuk, N.
    Surucu, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E722 - E723
  • [23] Biology-guided adaptive radiotherapy (BiGART) is progressing towards clinical reality
    Grau, Cai
    Overgaard, Jens
    Hoyer, Morten
    Tanderup, Kari
    Lindegaard, Jacob Christian
    Muren, Ludvig Paul
    ACTA ONCOLOGICA, 2015, 54 (09) : 1245 - 1250
  • [24] Biology-Guided Radiotherapy (BgRT) Emulated Delivery: Simulating Target Motion
    Bryant, S.
    Xu, S.
    Bal, H.
    Voronenko, Y.
    Tur, V.
    Garcia, J.
    Da Silva, A.
    Shao, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E103 - E103
  • [25] Commissioning of a novel PET-Linac for biology-guided radiotherapy (BgRT)
    Surucu, Murat
    Ashraf, Muhammad Ramish
    Romero, Ignacio Omar
    Zalavari, Laszlo Tibor
    Pham, Daniel
    Vitzthum, Lucas Kas
    Gensheimer, Michael Francis
    Yang, Yong
    Xing, Lei
    Kovalchuk, Nataliya
    Han, Bin
    MEDICAL PHYSICS, 2024, 51 (06) : 4389 - 4401
  • [26] Evaluation of Biology-Guided Radiotherapy Delivery to a Phantom Undergoing Periodic Motion
    Banks, T. I.
    Choi, M. G.
    Ghimire, S.
    Godley, A. R.
    Park, Y. K.
    Shen, C.
    Cai, B.
    MEDICAL PHYSICS, 2024, 51 (09) : 6608 - 6608
  • [27] Quantitative Assessment of Tracked Dose Delivery with Biology-Guided Radiotherapy (BgRT)
    Sharma, S.
    Groll, A.
    Da Silva, A.
    Narayanan, M.
    Kuduvalli, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E186 - E187
  • [28] Utility of Biology-Guided Radiotherapy to De Novo Metastases Diagnosed During Staging of High-Risk Biopsy-Proven Prostate Cancer
    Gaudreault, Mathieu
    Chang, David
    Hardcastle, Nicholas
    Jackson, Price
    Kron, Tomas
    Hanna, Gerard G.
    Hofman, Michael S.
    Siva, Shankar
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Initial Biology-guided Radiotherapy (BgRT) Phantom Design, Characterization and Planning with Multiple Asynchronous Targets for Metastatic Lung Treatment
    Groll, A.
    Schmall, J.
    Liang, H.
    Burns, J.
    Narayanan, M.
    Kuduvalli, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E132 - E132
  • [30] Intrafraction Dosimetric Evaluation of Biology-Guided Radiotherapy to a Target Under Respiratory Motion
    Bal, G.
    Kovalchuk, N.
    Schmall, J.
    Voronenko, Y.
    Bailey, T.
    Xu, S.
    Shi, L.
    Groll, A.
    Sharma, S.
    Ramos, K.
    Shao, L.
    Narayanan, M.
    Kuduvalli, G.
    Han, B.
    Surucu, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E680 - E681